PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis
Thu, 8 Aug

PROCTER & GAMBLE HEALTH has announced its results for the year ended December 2018. Let us have a look at the detailed performance review of the company during FY17-18.

PROCTER & GAMBLE HEALTH Income Statement Analysis

  • Operating income during the year rose 21.6% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 92.5% YoY during the fiscal. Operating profit margins witnessed a fall and down at 17.5% in CY18 as against 11.0% in CY17.
  • Depreciation charges increased by 10.5% increased by 0.0% YoY, respectively.
  • Other income grew by 1.3% YoY.
  • Net profit for the year grew by 66.7% YoY.
  • Net profit margins during the year grew from 8.5% in CY17 to 11.6% in CY18.

PROCTER & GAMBLE HEALTH Income Statement 2017-18

No. of Mths Year Ending 12 Dec-17* 12 Dec-18* % Change
Net Sales Rs m 6,981 8,490 21.6%
Other income Rs m 241 244 1.3%
Total Revenues Rs m 7,222 8,734 20.9%
Gross profit Rs m 770 1,482 92.5%
Depreciation Rs m 191 211 10.5%
Interest Rs m 0 0 0.0%
Profit before tax Rs m 819 1,514 84.9%
Tax Rs m 379 563 48.5%
Profit after tax Rs m 610 1,017 66.7%
Gross profit margin % 11.0 17.5
Effective tax rate % 46.2 37.1
Net profit margin % 8.5 11.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



PROCTER & GAMBLE HEALTH Balance Sheet Analysis

  • The company's current liabilities during CY18 down at Rs 2 billion as compared to Rs 2 billion in CY17, thereby witnessing an decrease of -13.0%.
  • Current assets rose 104% and stood at Rs 15 billion, while fixed assets fell 2% and stood at Rs 1 billion in CY18.
  • Overall, the total assets and liabilities for CY18 stood at Rs 18 billion as against Rs 10 billion during CY17, thereby witnessing a growth of 78%.

PROCTER & GAMBLE HEALTH Balance Sheet as on December 2018

No. of Mths Year Ending 12 Dec-17* 12 Dec-18* % Change
Networth Rs m 7,333 15,401 110.0
 
Current Liabilities Rs m 2,253 1,960 -13.0
Long-term Debt Rs m 0 0 0.0
Total Liabilities Rs m 9,912 17,595 77.5
 
Current assets Rs m 7,523 15,343 103.9
Fixed Assets Rs m 1,240 1,209 -2.5
Total Assets Rs m 9,912 17,595 77.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



PROCTER & GAMBLE HEALTH Cash Flow Statement Analysis

  • PROCTER & GAMBLE HEALTH's cash flow from operating activities (CFO) during CY18 stood at Rs -1 billion on a YoY basis.
  • Cash flow from investing activities (CFI) during CY18 stood at Rs 13 billion on a YoY basis.
  • Cash flow from financial activities (CFF) during CY18 stood at Rs -301 million on a YoY basis.
  • Overall, net cash flows for the company during CY18 stood at Rs 11 billion from the Rs -160 million net cash flows seen during CY17.

PROCTER & GAMBLE HEALTH Cash Flow Statement 2017-18

Particulars No. of months 12 12 % Change
Year Ending Dec-17 Dec-18
Cash Flow from Operating Activities Rs m 537 -1,304 -
Cash Flow from Investing Activities Rs m -476 12,697 -
Cash Flow from Financing Activities Rs m -220 -301 -
Net Cash Flow Rs m -160 11,093 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



Current Valuations for PROCTER & GAMBLE HEALTH

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 61.3, an improvement from the EPS of Rs 36.8 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 4,610.0, stands at 59.7 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 2.6 times, while the price to sales ratio stands at 4.7 times.
  • The company's price to cash flow (P/CF) ratio stood at 62.3 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Dec-17* 12 Dec-18*
Sales per share (Unadj.) Rs 420.6 511.4
TTM Earnings per share Rs 36.8 61.3
Diluted earnings per share Rs 36.8 61.3
Price to Cash Flow x 95.5 62.3
TTM P/E ratio x 59.7 59.7
Price / Book Value ratio x 2.6 2.6
Market Cap Rs m 76,526 76,526
Dividends per share (Unadj.) Rs 15.0 440.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



Ratio Analysis for PROCTER & GAMBLE HEALTH

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 7.8x during CY18, from 3.3x during CY17. The current ratio measures the company's ability to pay short-term and long-term obligations.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 6.6% during CY18, from 8.3% during CY18. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 10.3% during CY18, from 13.5% during CY17. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 5.8% during CY18, from 6.2% during CY17. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Dec-17* 12 Dec-18*
Current ratio x 3.3 7.8
Debtors’ Days Days 64 28
Interest coverage x 0.0 0.0
Debt to equity ratio x 0.0 0.0
Return on assets % 6.2 5.8
Return on equity % 8.3 6.6
Return on capital employed % 13.5 10.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster



To see how PROCTER & GAMBLE HEALTH has performed over the last 5 years, please visit here.

PROCTER & GAMBLE HEALTH Share Price Performance

Over the last one year, PROCTER & GAMBLE HEALTH share price has moved up from Rs 2,954.2 to Rs 4,610.0, registering a gain of Rs 1,655.8 or around 56.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,604.9 (up 0.3%). Over the last one year it has moved down from 14,502.8 to 12,604.9, a loss of 1,898 points (down 13.1%).

Overall, the S&P BSE SENSEX is down 2.2% over the year.

(To know more, check out historical annual results for PROCTER & GAMBLE HEALTH and quarterly results for PROCTER & GAMBLE HEALTH)

Equitymaster requests your view! Post a comment on "PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis". Click here!

  

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - ADCOCK INGRAM COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS